VANOLI, EMILIO
 Distribuzione geografica
Continente #
NA - Nord America 2.879
AS - Asia 2.349
EU - Europa 2.142
SA - Sud America 235
AF - Africa 37
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.651
Nazione #
US - Stati Uniti d'America 2.833
CN - Cina 1.415
IE - Irlanda 530
SG - Singapore 497
DE - Germania 351
UA - Ucraina 320
FI - Finlandia 275
HK - Hong Kong 231
RU - Federazione Russa 207
BR - Brasile 195
SE - Svezia 173
IT - Italia 111
GB - Regno Unito 94
VN - Vietnam 64
IN - India 41
CA - Canada 30
FR - Francia 27
AR - Argentina 19
ID - Indonesia 16
BD - Bangladesh 14
BE - Belgio 13
MX - Messico 12
NL - Olanda 12
JP - Giappone 11
ZA - Sudafrica 10
EC - Ecuador 8
IQ - Iraq 8
MA - Marocco 8
ES - Italia 7
TR - Turchia 7
AE - Emirati Arabi Uniti 6
MU - Mauritius 6
JO - Giordania 5
KE - Kenya 5
PK - Pakistan 5
PL - Polonia 5
SA - Arabia Saudita 5
AU - Australia 4
CO - Colombia 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
PH - Filippine 3
PY - Paraguay 3
TH - Thailandia 3
TN - Tunisia 3
BH - Bahrain 2
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
IR - Iran 2
KW - Kuwait 2
LT - Lituania 2
MY - Malesia 2
PT - Portogallo 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 7.651
Città #
Dublin 526
Chandler 524
Jacksonville 415
Nanjing 354
Beijing 239
Dallas 237
Hong Kong 231
Singapore 216
Ashburn 181
Boardman 148
Munich 140
Nanchang 135
Changsha 99
Lawrence 97
Princeton 97
Medford 96
Helsinki 85
Hebei 83
Shenyang 77
Wilmington 74
Jiaxing 73
Ann Arbor 66
Los Angeles 62
Hangzhou 55
Tianjin 46
Redondo Beach 37
Milan 35
Woodbridge 35
Buffalo 32
Moscow 28
Norwalk 26
Pune 25
São Paulo 22
New York 20
Shanghai 20
Turku 19
Ho Chi Minh City 16
Zhengzhou 16
Verona 15
Brussels 13
Des Moines 13
Montreal 13
Hanoi 12
Falkenstein 11
Falls Church 11
Guangzhou 11
Tokyo 11
Council Bluffs 10
Orem 10
Pavia 10
Brooklyn 9
Houston 9
Jakarta 9
Phoenix 9
Rio de Janeiro 9
Seattle 9
Toronto 9
Chicago 8
Johannesburg 8
Nuremberg 8
Washington 8
Ningbo 7
Stockholm 7
Atlanta 6
Chongqing 6
Denver 6
Fuzhou 6
Kunming 6
London 6
Poplar 6
San Francisco 6
The Dalles 6
Amman 5
Chennai 5
Nairobi 5
San Jose 5
Santa Clara 5
Warsaw 5
Ankara 4
Auburn Hills 4
Auckland 4
Guayaquil 4
Orange 4
Querétaro 4
Szeged 4
Bangkok 3
Bekasi 3
Belo Horizonte 3
Biên Hòa 3
Brasília 3
Buenos Aires 3
Caxias do Sul 3
Changchun 3
Dearborn 3
Florianópolis 3
Haiphong 3
Manchester 3
Piracicaba 3
Riyadh 3
Rome 3
Totale 5.093
Nome #
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. 286
Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial 133
[Electrophysiologic features of the modulation of ATP-dependent potassium channels]. 119
N-ACETIL CISTEINA PER L’USO NEURASSIALE COME INIBITORE DEL RECETTORE TIROSIN CHINASICO TRKA PER IL TRATTAMENTO DEL DOLORE ACUTO E CRONICO 118
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 116
Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain 113
ANTI STUNNING EFFECT OF POST 2744 IN AN HIGT AFTER LOAD, ISCHEMIA /REPERFUSION CANINE MODEL 113
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. 112
Alpha 1-adrenergic blockade and sudden cardiac death. 110
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 107
Autonomic control of heart rate: Pharmacological and nonpharmacological modulation 106
Baroreflex sensitivity: methods, mechanisms, and prognostic value 106
Adaptive servo ventilation reduces central sleep apnea in chronic heart failure patients: beneficial effects on autonomic modulation of heart rate. 104
NOVEL APPROACHES TO THE POST-MYOCARDIAL INFARCTION/ HEART FAILURE NEURAL REMODELING 104
Assessing the pattern of ST-segment depression during subendocardial ischemia using a computer simulation of the ventricular electrogram. 103
Autonomic control of heart rate: pharmacological and nonpharmacological modulation. 101
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 100
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. 98
Scompenso cardiaco cronico e morte improvvisa: il messaggio del CIBIS III. 97
An experimental approach to the choice of antiarrhythmic therapy. 97
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. 95
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. 94
Brain and Heart Dynamics 92
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 91
NERVE GROWTH FACTOR: A POTENTIAL NOVEL BIOMARKER IN HEART FAILURE 91
Experimental models of heart failure. 90
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 90
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 90
PEPTIDI AVENTI ATTIVITÀ AGONISTA NEI CONFRONTI DEL RECETTORE TrkA E/O PEPTIDI AVENTI ATTIVITÀ ANTAGONISTA DI NGF 89
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 88
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. 88
Adrenergic effects on force-frequency relationship: a pivotal role for the cardiac intrinsic systems. 86
K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. 85
Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade. 84
KIT PER RILEVARE I LIVELLI DI CONTENUTO PLASMATICO DI MATERIALE NGF IMMUNOREATTIVO 83
Correlazione tra profilo autonomico e fenotipo ecocardiografico in pazienti con cardiomiopatia ipertrofica. 82
T wave alternans detection during exercise stress test and during dobutamine stress. A comparative study in patients with a recent myocardial infarction. 81
Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity: a new experimental model for the study of antiarrhythmic drugs. 80
Lack of correlation between occlusion and reperfusion arrhythmias in the cat. 78
Ephedrine Increases Ventricular Arrhythmias in Conscious Dogs After Myocardial Infarction 78
Sudden death prevention in heart failure: The case of CIBIS III 77
Heart rate variability and risk stratification post-myocardial infarction 77
NGF AND HEART: IS THERE A ROLE IN HEART DISEASE? 76
Efficacy of diltiazem in two experimental feline models of sudden cardiac death. 76
Early autonomic and repolarization abnormalities contribute to lethal arrhythmias in chronic ischemic heart failure. Characteristics of a novel heart failure model in conscious dogs with post-myocardial infarction left ventricular dysfunction 76
What does the future hold for the management of chronic heart failure? 75
RIMODELLAMENTO AUTONOMICO DOPO INFARTO MIOCARDICO 75
Dietary Omega-3 Fatty Acids and Susceptibility to Ventricular Fibrillation: Lack of Protection and A Proarrhythmic Effect. 74
Hemodynamic effects of a new inotropic compound, PST-2744, in dogs with chronic ischemic heart failure. 73
Sympathomimetic inefficiency in restoring contractility in the acute or chronic beta-blocker-treated ischaemic heart: comparison with a new agent. 73
Istaroxime: a new luso-inotropic agent for heart failure 72
The role of cardiac resynchronization devices in monitoring patients with chronic heart failure 72
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. 72
Prediction of unexpected sudden death among healthy dogs by a novel marker of autonomic neural activity. 72
Prevention of Sudden Death in Heart Failure 71
Electrophysiologic features of the modulation of ATP-dependent potassium channels. 70
Influence of residual ischaemia on heart rate variability after myocardial infarction. 69
Vagal activity and ventricular fibrillation 69
Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. 68
Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs 68
Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. 67
Muscarinic effects on action potential duration and its rate dependence in canine Purkinje fibers 67
Multislice computed tomography for the evaluation of coronary bypass grafts and native coronary arteries: comparison with traditional angiography. 67
QT interval and baroreflex sensitivity in conscious dogs before and after myocardial infarction 67
Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. 65
Stress-induced QTc-interval shortening as an ancillary marker of ischemia in patients with complete left bundle branch block. 65
Combined sodium and calcium channel blockade in prevention of lethal arrhythmias. 64
Heart rate variability before and after myocardial infarction in conscious dogs at high and low risk of sudden death. 63
Tocainide and mortality after myocardial infarction: a prospective study in conscious dogs. 63
Methods for assessment of vagal reflexes 63
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. 63
Five-minute recording of heart rate variability in severe chronic heart failure: correlates with right ventricular function and prognostic implications 62
Cardiac vagal activity, myocardial ischemia and sudden death 61
Hemodynamic effects of a new inotropic compound, PST-2744, in dogs with chronic ischemic heart failure. 61
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: Final 43-month study report 61
Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia 60
Use of dual-flow bioreactor to develop a simplified model of nervous-cardiovascular systems crosstalk: A preliminary assessment 60
Influences of residual ischaemia on heart rate variability after myocardial infarction. 59
Sympathetic--parasympathetic interaction and sudden death 59
From exercise training to sudden death prevention via adrenergic receptors. 58
Carbon monoxide and lethal arrhythmias in conscious dogs with a healed myocardial infarction. 58
The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity. 58
Heart rate variability during specific sleep stages. A comparison of healthy subjects with patients after myocardial infarction. 58
Effects of vagal stimulation in conscious dogs with previous myocardial infarct. 57
Pertussis toxin-induced ADP ribosylation of inhibitor G proteins alters vagal control of heart rate in vivo. 57
Unexpected interaction between beta-adrenergic blockade and heart rate variability before and after myocardial infarction. A longitudinal study in dogs at high and low risk for sudden death. 56
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure 56
Experimental evaluation of antiarrhythmic drugs efficacy. 54
Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction 51
Heterogeneous regional endocardial repolarization is associated with increased risk for ischemia-dependent ventricular fibrillation after myocardial infarction. 51
Sympathetic activation, ventricular repolarization and IKr blockade: Implications for the antifibrillatory efficacy of K+ channel blocking agents 50
Response of cytochrome a,a3 to carbon monoxide in canine hearts with prior infarcts. 48
Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction 46
Carbon monoxide and lethal arrhythmias. 43
N-Acetylcysteine Antagonizes NGF Activation of TrkA through Disulfide Bridge Interaction, an Effect Which May Contribute to Its Analgesic Activity 42
Predictors of medical events and of their competitive interactions in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2). 41
Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial ischemia and reperfusion. 39
Challenges in personalised management of chronic diseases-heart failure as prominent example to advance the care process 37
Totale 7.690
Categoria #
all - tutte 31.910
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.910


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021394 0 0 0 0 0 77 5 89 27 93 82 21
2021/2022478 5 3 10 7 13 46 9 26 26 17 67 249
2022/20231.474 157 94 23 131 150 143 0 99 606 10 39 22
2023/2024388 30 101 16 42 42 94 2 17 0 18 21 5
2024/20251.336 23 130 41 45 26 81 95 120 301 33 132 309
2025/20261.473 226 178 349 279 276 165 0 0 0 0 0 0
Totale 7.690